About this trial
The purpose of this study is to evaluate the hemodynamics and adverse event profile in comparison between two treatment arms, one using an admixture of propofol and etomidate at a ratio by volume of 25%/75% (P2E7), and one using an admixture of propofol and etomidate at a ratio by volume of 75%/25% (P7E2), for anesthesia during endoscopic procedures at the Clements University Hospital (CUH) endoscopy lab (Endo).
Eligibility criteria
Qualifiers
Adult patients (age ≥18 years old)
Having endoscopic procedure at CUH with anesthesia
ASA 3 or above
Ejection Fraction test result available
Disqualifiers
Known allergies or adverse reactions to study drugs or study drug components or preservatives
Patient refusal
Clinician refusal
Documented cognitive impairments precluding subject ability to consent for themselves unless a surrogate documented legally acceptable decision maker consents for patient participation
Trial design
Treatments tested in this trial
- Admixture of propofol and etomidate at a ratio by volume of 75%/25% (P7E2)
- Admixture of propofol and etomidate at a ratio by volume of 25%/75% (P2E7)